These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21375975)

  • 1. [Eculizumab in paroxysmal nocturnal hemoglobinuria].
    Birgens H
    Ugeskr Laeger; 2011 Mar; 173(10):714. PubMed ID: 21375975
    [No Abstract]   [Full Text] [Related]  

  • 2. Eculizumab (Soliris) for paroxysmal nocturnal hemoglobinuria.
    Med Lett Drugs Ther; 2007 Sep; 49(1270):79-80. PubMed ID: 17878890
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria.
    Hillmen P; Hall C; Marsh JC; Elebute M; Bombara MP; Petro BE; Cullen MJ; Richards SJ; Rollins SA; Mojcik CF; Rother RP
    N Engl J Med; 2004 Feb; 350(6):552-9. PubMed ID: 14762182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eculizumab in paroxysmal nocturnal hemoglobinuria.
    Pride YB
    N Engl J Med; 2006 Dec; 355(26):2787; author reply 2787-8. PubMed ID: 17195305
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evidence of the efficacy of eculizumab in paroxysmal nocturnal hemoglobinuria].
    Nau JY
    Rev Med Suisse; 2006 Oct; 2(81):2255. PubMed ID: 17076159
    [No Abstract]   [Full Text] [Related]  

  • 6. Eculizumab opens a new era of treatment for paroxysmal nocturnal hemoglobinuria.
    Schrezenmeier H; Höchsmann B
    Expert Rev Hematol; 2009 Feb; 2(1):7-16. PubMed ID: 21082989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eculizumab in paroxysmal nocturnal hemoglobinuria.
    Takita M; Matsumura T; Kami M
    N Engl J Med; 2006 Dec; 355(26):2787; author reply 2787-8. PubMed ID: 17193722
    [No Abstract]   [Full Text] [Related]  

  • 8. Update on eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria.
    Hill A
    Clin Adv Hematol Oncol; 2008 Jul; 6(7):499-500. PubMed ID: 18654116
    [No Abstract]   [Full Text] [Related]  

  • 9. Eculizumab in paroxysmal nocturnal hemoglobinuria.
    Singh J; Malani AK; Pabla M
    N Engl J Med; 2006 Dec; 355(26):2786; author reply 2787-8. PubMed ID: 17195307
    [No Abstract]   [Full Text] [Related]  

  • 10. Eculizumab in paroxysmal nocturnal hemoglobinuria.
    Kathula SK
    N Engl J Med; 2006 Dec; 355(26):2786; author reply 2787-8. PubMed ID: 17192547
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiopulmonary bypass in a patient with classic paroxysmal nocturnal hemoglobinuria during treatment with eculizumab.
    van Bijnen ST; Vermeer H; Mourisse JM; de Witte T; van Swieten HA; Muus P
    Eur J Haematol; 2011 Oct; 87(4):376-8. PubMed ID: 21623921
    [No Abstract]   [Full Text] [Related]  

  • 12. Paroxysmal nocturnal hemoglobinuria (PNH) and pregnancy in the era of eculizumab.
    Danilov AV; Smith H; Craigo S; Feeney DM; Relias V; Miller KB
    Leuk Res; 2009 Jun; 33(6):e4-5. PubMed ID: 18952283
    [No Abstract]   [Full Text] [Related]  

  • 13. Eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria.
    Hill A
    Clin Adv Hematol Oncol; 2005 Nov; 3(11):849-50. PubMed ID: 16491626
    [No Abstract]   [Full Text] [Related]  

  • 14. Eculizumab effect on the hemostatic state in patients with paroxysmal nocturnal hemoglobinuria.
    Seregina EA; Tsvetaeva NV; Nikulina OF; Zapariy AP; Erasov AV; Gribkova IV; Orel EB; Ataullakhanov FI; Balandina AN
    Blood Cells Mol Dis; 2015 Feb; 54(2):144-50. PubMed ID: 25497169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria.
    Hillmen P; Young NS; Schubert J; Brodsky RA; Socié G; Muus P; Röth A; Szer J; Elebute MO; Nakamura R; Browne P; Risitano AM; Hill A; Schrezenmeier H; Fu CL; Maciejewski J; Rollins SA; Mojcik CF; Rother RP; Luzzatto L
    N Engl J Med; 2006 Sep; 355(12):1233-43. PubMed ID: 16990386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eculizumab for patients with paroxysmal nocturnal hemoglobinuria (PNH) is effective during the maintenance of hemodialysis for end stage renal failure.
    Kelly RJ; Hill A; Arnold LM; Khursigara G; Kanagasundaram NS; Hillmen P
    Leuk Res; 2011 Apr; 35(4):560-2. PubMed ID: 21145109
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA report: eculizumab (Soliris) for the treatment of patients with paroxysmal nocturnal hemoglobinuria.
    Dmytrijuk A; Robie-Suh K; Cohen MH; Rieves D; Weiss K; Pazdur R
    Oncologist; 2008 Sep; 13(9):993-1000. PubMed ID: 18784156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid antibodies in patients with paroxysmal nocturnal haemoglobinuria receiving eculizumab.
    Darnige L; Peffault de Latour R; Zemori L; Socié G; Fischer AM; Helley D;
    Br J Haematol; 2011 Jun; 153(6):789-91. PubMed ID: 21457219
    [No Abstract]   [Full Text] [Related]  

  • 19. [Successful eculizumab treatment for multiple coronary thrombosis complicated in paroxysmal nocturnal hemoglobinuria].
    Taniguchi A; Ikezoe T; Takeuchi A; Togitani K; Yoshimoto M; Tanioka K; Kitaoka H; Yokoyama A
    Rinsho Ketsueki; 2014 Aug; 55(8):965-9. PubMed ID: 25186487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of eculizumab in patients with paroxysmal nocturnal hemoglobinuria (PNH) with or without aplastic anemia in the International PNH Registry.
    Lee JW; Peffault de Latour R; Brodsky RA; Jang JH; Hill A; Röth A; Schrezenmeier H; Wilson A; Marantz JL; Maciejewski JP
    Am J Hematol; 2019 Jan; 94(1):E37-E41. PubMed ID: 30370949
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.